Literature DB >> 19421145

PLZF-mediated control on c-kit expression in CD34(+) cells and early erythropoiesis.

I Spinello1, M T Quaranta, L Pasquini, E Pelosi, E Petrucci, A Pagliuca, G Castelli, G Mariani, D Diverio, R Foà, U Testa, C Labbaye.   

Abstract

The promyelocytic leukemia zinc-finger protein (PLZF) is a transcription factor and c-kit is a receptor tyrosine kinase associated with human disease, particularly in hematopoietic cells. MicroRNAs (miRs) are post-transcriptional regulators of gene expression, and c-kit has been described as a target of miRs-221 and -222 in erythropoiesis. In the present study, we identified c-kit as a target of PLZF in normal and leukemic cells. Particularly, in erythropoietic (E) culture of CD34(+) progenitors, PLZF is downregulated, whereas c-kit expression at both the mRNA and protein levels inversely increases during the first days of E differentiation. In functional experiments, PLZF transfection induces c-kit downregulation, inhibits E proliferation and delays differentiation, whereas PLZF knockdown induces opposite effects, independently of miRs-221 and -222 expression. The inverse correlation between PLZF and c-kit expression was found in normal CD34(+)38(+/-) hematopoietic progenitor/stem cells and in acute myeloid leukemias of M0/M1 French-American-British subtypes, suggesting that the control of PLZF on c-kit expression may be crucial at the level of the stem cell/progenitor compartment. Altogether, our data indicate a new mechanism of regulation of c-kit expression that involves a transcriptional control by PLZF in CD34(+) cells and early erythropoiesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19421145     DOI: 10.1038/onc.2009.87

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  13 in total

1.  Phospho-proteomic discovery of novel signal transducers including thioredoxin-interacting protein as mediators of erythropoietin-dependent human erythropoiesis.

Authors:  Matthew A Held; Emily Greenfest-Allen; Edward Jachimowicz; Christian J Stoeckert; Matthew P Stokes; Antony W Wood; Don M Wojchowski
Journal:  Exp Hematol       Date:  2020-04-04       Impact factor: 3.084

2.  8-CPT-cAMP/all-trans retinoic acid targets t(11;17) acute promyelocytic leukemia through enhanced cell differentiation and PLZF/RARα degradation.

Authors:  Bo Jiao; Zhi-Hong Ren; Ping Liu; Li-Juan Chen; Jing-Yi Shi; Ying Dong; Julien Ablain; Lin Shi; Li Gao; Jun-Pei Hu; Rui-Bao Ren; Hugues de Thé; Zhu Chen; Sai-Juan Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

3.  MicroRNAs 221 and 222 regulate the undifferentiated state in mammalian male germ cells.

Authors:  Qi-En Yang; Karen E Racicot; Amy V Kaucher; Melissa J Oatley; Jon M Oatley
Journal:  Development       Date:  2012-12-05       Impact factor: 6.868

Review 4.  Renin-angiotensin system in ureteric bud branching morphogenesis: implications for kidney disease.

Authors:  Ihor V Yosypiv
Journal:  Pediatr Nephrol       Date:  2013-09-07       Impact factor: 3.714

5.  Role of stem cell factor in the reactivation of human fetal hemoglobin.

Authors:  Marco Gabbianelli; Ugo Testa
Journal:  Mediterr J Hematol Infect Dis       Date:  2009-11-13       Impact factor: 2.576

6.  (Pro)renin Receptor in Kidney Development and Disease.

Authors:  Renfang Song; Ihor V Yosypiv
Journal:  Int J Nephrol       Date:  2011-06-20

7.  MicroRNA-146a and AMD3100, two ways to control CXCR4 expression in acute myeloid leukemias.

Authors:  I Spinello; M T Quaranta; R Riccioni; V Riti; L Pasquini; A Boe; E Pelosi; A Vitale; R Foà; U Testa; C Labbaye
Journal:  Blood Cancer J       Date:  2011-06-24       Impact factor: 11.037

8.  MiR-221 influences effector functions and actin cytoskeleton in mast cells.

Authors:  Ramon J Mayoral; Lorenzo Deho; Nicole Rusca; Nenad Bartonicek; Harpreet Kaur Saini; Anton J Enright; Silvia Monticelli
Journal:  PLoS One       Date:  2011-10-12       Impact factor: 3.240

9.  Increase of microRNA-210, decrease of raptor gene expression and alteration of mammalian target of rapamycin regulated proteins following mithramycin treatment of human erythroid cells.

Authors:  Nicoletta Bianchi; Alessia Finotti; Manuela Ferracin; Ilaria Lampronti; Cristina Zuccato; Giulia Breveglieri; Eleonora Brognara; Enrica Fabbri; Monica Borgatti; Massimo Negrini; Roberto Gambari
Journal:  PLoS One       Date:  2015-04-07       Impact factor: 3.240

10.  Methods to Investigate miRNA Function: Focus on Platelet Reactivity.

Authors:  Alix Garcia; Sylvie Dunoyer-Geindre; Richard J Fish; Marguerite Neerman-Arbez; Jean-Luc Reny; Pierre Fontana
Journal:  Thromb Haemost       Date:  2020-10-29       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.